newsfilter
← Latest News
GlobeNewswire·

PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB:PHRRF) (CSE:PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical